{"gene":"ADH5","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1984,"finding":"Human formaldehyde dehydrogenase (FDH/ADH5) is a dimeric enzyme encoded on chromosome 4, with a functional molecule composed of two identical subunits.","method":"Biochemical isozyme analysis, somatic cell hybrid mapping","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct biochemical characterization and chromosomal mapping, single study","pmids":["6467984"],"is_preprint":false},{"year":1992,"finding":"ADH5 (FDH) gene is composed of nine exons and eight introns; its 5' region is a CpG island lacking TATA and CAAT boxes, consistent with ubiquitous expression; two major transcription start points were identified; and a 1.5-kb upstream fragment drives transcription in heterologous cells.","method":"Genomic cloning, primer extension, reporter gene (CAT) assay","journal":"Gene","confidence":"High","confidence_rationale":"Tier 1 — direct molecular characterization with mutagenesis-equivalent reporter assays","pmids":["1446828"],"is_preprint":false},{"year":1999,"finding":"Sp1 drives ADH5/FDH transcription through two core cis-elements (−22 bp to +22 bp); Sp3 and Sp4 repress transcription by competing with Sp1 for these same binding sites via their zinc-finger domains.","method":"Mutagenesis of cis-elements, reporter assay in Drosophila SL2 cells (lacking Sp1), EMSA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in Sp1-null cells with mutagenesis and EMSA, replicated across multiple cell types","pmids":["9867805"],"is_preprint":false},{"year":2000,"finding":"The human ADH5 gene produces at least two transcript variants via alternative polyadenylation/splicing at a composite internal/terminal exon, generating C-terminal multiplicity; the full-length variant is the major transcript in adult liver.","method":"PCR amplification of 3'-cDNA ends, Northern blot, genomic sequencing","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — multiple molecular methods in single study","pmids":["11095947"],"is_preprint":false},{"year":2002,"finding":"The POZ domain transcription factor FBI-1 binds the ADH5/FDH promoter (−38 to −22 bp) in vitro and in vivo, represses ADH5/FDH transcription by directly interacting with the zinc-finger domain of Sp1, and interferes with Sp1 binding to GC boxes.","method":"EMSA, ChIP, GST pull-down, DNase I footprinting, reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including pull-down and footprinting in a single study","pmids":["12004059"],"is_preprint":false},{"year":2010,"finding":"GSNOR (ADH5) deficiency leads to S-nitrosylation and proteasomal degradation of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT), impairing repair of O6-alkylguanines and promoting hepatocarcinogenesis; this is abrogated by concomitant iNOS deficiency.","method":"GSNOR knockout mice, carcinogen challenge, biochemical AGT quantification, epistasis with iNOS KO","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined molecular phenotype and genetic epistasis, replicated in multiple models","pmids":["20371487"],"is_preprint":false},{"year":2010,"finding":"Overexpression of fdh (Drosophila GSNOR homolog) in the fan-shaped body (but not mushroom body) impairs visual pattern memory; the defect is rescued by co-expression of cGMP-dependent protein kinase (PKG), linking GSNOR-dependent NO/S-nitrosation metabolism to learning and memory via the NO-cGMP-PKG pathway.","method":"Gal4/UAS system for tissue-specific overexpression in Drosophila, behavioral assays, enzymatic activity measurement","journal":"Nitric oxide : biology and chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic manipulation with defined cellular/behavioral phenotype and epistasis rescue","pmids":["20932929"],"is_preprint":false},{"year":2011,"finding":"Targeted hepatocyte-specific deletion of GSNOR (ADH5), but not hematopoietic-lineage deletion, leads to S-nitrosylation and depletion of AGT, increased DNA double-strand breaks, and elevated sensitivity to nitrosamine-induced genotoxicity; this is abolished by iNOS co-deficiency.","method":"Conditional (cell-type-specific) knockout mice, liver AGT quantification, γH2AX staining, epistasis with iNOS","journal":"Carcinogenesis","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with defined molecular phenotype and genetic epistasis","pmids":["21385828"],"is_preprint":false},{"year":2013,"finding":"GSNOR (ADH5) deficiency promotes hepatocellular carcinoma at the tumor initiation stage; pharmacological iNOS inhibition (1400W) after carcinogen exposure rescues AGT depletion and O6-ethyldeoxyguanosine repair and reduces HCC multiplicity in GSNOR-deficient mice to wild-type levels.","method":"GSNOR KO mice, pharmacological iNOS inhibition, DNA adduct measurement, tumor endpoint analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — pharmacological and genetic epistasis with molecular readouts, replicated","pmids":["23440427"],"is_preprint":false},{"year":2013,"finding":"GSNOR deficiency in mesenchymal stem cells impairs vasculogenesis by downregulating PDGFRα, a receptor essential for VEGF-A action; restoration through NOS inhibition or GHRH agonists normalizes tube formation via PDGFRα.","method":"GSNOR KO MSCs, Matrigel tube-forming assay, pharmacological NOS inhibition, in vivo implantation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches including in vitro and in vivo models with pharmacological rescue","pmids":["23288904"],"is_preprint":false},{"year":2016,"finding":"Human GSNOR (ADH5) is inhibited by S-nitrosation of conserved non-zinc-coordinating cysteine residues; nitrosation causes decreased tryptophan fluorescence, increased thermal aggregation, and increased polydispersity, with allosteric conformational changes near the substrate- and coenzyme-binding pockets detected by HDX-MS; DTT restores activity.","method":"In vitro enzyme assay with nitroso donors, mass spectrometry (S-nitrosation detection), HDX-MS, site-directed mutagenesis of cysteines, fluorescence, thermal stability assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis, mass spectrometry confirmation, and structural dynamics by HDX-MS","pmids":["27064847"],"is_preprint":false},{"year":2017,"finding":"GSNOR (ADH5) metabolizes GSNO (S-nitrosoglutathione), S-hydroxymethylglutathione (the spontaneous formaldehyde-glutathione adduct), and some alcohols; it modulates NO bioavailability and indirectly regulates protein S-nitrosylation through GSNO-mediated transnitrosation.","method":"Enzymatic substrate characterization (review of biochemical data)","journal":"Critical reviews in biochemistry and molecular biology","confidence":"High","confidence_rationale":"Tier 1 — established substrate specificity reviewed from multiple biochemical studies","pmids":["28393572"],"is_preprint":false},{"year":2017,"finding":"GSNOR (ADH5) expression increases in the hippocampus during aging; GSNOR transgenic mice show cognitive impairment, LTP defects, and lower dendritic spine density; these are associated with decreased S-nitrosation of CaMKIIα at C280/C289, reducing CaMKIIα synaptosomal accumulation and downstream p(S831)-GluR1 signaling; GSNOR KO mice rescue age-related cognitive impairment.","method":"Transgenic overexpression and KO mice, behavioral tests (Morris water maze, fear conditioning, Y-maze), LTP recording, synaptosomal fractionation, site-directed mutagenesis of CaMKIIα S-nitrosation sites","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including mutagenesis of modification sites, behavioral, electrophysiological, and biochemical readouts","pmids":["28883020"],"is_preprint":false},{"year":2018,"finding":"GSNOR deficiency increases S-nitrosylation of Akt at Cys224 in T cells, reducing Akt phosphorylation at Ser473 and impairing Akt signaling; HHcy induces GSNOR, reducing S-nitrosylation and activating T cells, promoting atherosclerosis; adoptive transfer of GSNOR-/- T cells reduces atherosclerosis.","method":"Site-directed mutagenesis of Akt C224, GSNOR KO and ApoE KO mice, adoptive transfer, S-nitrosylation measurement","journal":"Redox biology","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis of modification site combined with KO genetics and adoptive transfer","pmids":["29860106"],"is_preprint":false},{"year":2019,"finding":"GSNOR exhibits allosteric activation by its substrate GSNO; kinetic analysis revealed non-hyperbolic behavior with Hill coefficient ~1.75; an allosteric GSNO-binding site comprises residues Asn185, Lys188, Gly321, and Lys323 near the structural Zn2+-binding domain; site-directed mutagenesis of Lys188Ala and Lys323Ala abolishes allosteric behavior.","method":"Enzyme kinetics, molecular docking, HDX-MS, site-directed mutagenesis","journal":"Antioxidants (Basel, Switzerland)","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinetics, mutagenesis confirming allosteric site residues, structural dynamics by HDX-MS","pmids":["31766125"],"is_preprint":false},{"year":2019,"finding":"GSNOR co-localizes with nNOS at the sarcolemma of skeletal muscle cells and co-immunoprecipitates with nNOS in C2C12 cells and myofibers; GSNOR expression decreases in models of muscular dystrophy, aging, and ALS.","method":"Co-immunoprecipitation, co-localization (immunofluorescence), C2C12 differentiation model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP and co-localization, single lab","pmids":["31043586"],"is_preprint":false},{"year":2020,"finding":"Digenic loss of ADH5 (formaldehyde dehydrogenase) and ALDH2 causes AMeD syndrome (aplastic anemia, mental retardation, dwarfism) due to formaldehyde accumulation and resultant DNA damage that overwhelms hematopoietic stem cell capacity; Adh5 E506K/E506K mice recapitulate features including dwarfism and hematopoietic failure.","method":"Patient exome sequencing, cellular formaldehyde tolerance assays, mouse knockin model (E506K), hematopoietic differentiation assays","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 — disease modeling with patient-derived cells, mouse model recapitulation, and cellular mechanistic studies","pmids":["33355142"],"is_preprint":false},{"year":2020,"finding":"GSNOR (ADH5) is induced at the translational level by hydrogen peroxide and mitochondrial ROS downstream of ATM kinase, which phosphorylates and activates CHK2 and p53; this ATM/GSNOR axis sustains mitophagy and protects against nitrosative and oxidative stress.","method":"Selective pharmacological inhibitors, siRNA knockdown, redox-insensitive ATM mutant expression, cell viability and mitophagy assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — pharmacological and genetic epistasis with multiple orthogonal methods","pmids":["33245190"],"is_preprint":false},{"year":2020,"finding":"ADH5 loss in brown adipose tissue impairs cold-induced UCP1-dependent thermogenesis and worsens obesity-associated metabolic dysfunction; ADH5 expression is induced by the transcription factor HSF1, and HSF1 activation increases Adh5 expression and improves UCP1-mediated respiration.","method":"BAT-specific ADH5 KO, cold exposure, UCP1 S-nitrosylation measurement, HSF1 activator treatment, metabolic phenotyping","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific KO with defined metabolic phenotype and transcription factor identification","pmids":["34788615"],"is_preprint":false},{"year":2021,"finding":"ADH5 is the primary defense against endogenous formaldehyde, with ALDH2 providing backup; ADH5/ALDH2-deficient iPSCs show defective cell expansion upon hematopoietic differentiation with increased DNA damage, which is reversed by an ALDH2 agonist (compound C1).","method":"Patient-derived iPSCs, hematopoietic differentiation assays, DNA damage quantification, SCE analysis, pharmacological rescue","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — disease-model iPSCs with defined molecular and cellular phenotypes and pharmacological rescue","pmids":["33512438"],"is_preprint":false},{"year":2021,"finding":"GSNOR deficiency enhances S-nitrosylation of TBK1 at Cys423, inhibiting TBK1 kinase activity and reducing interferon production, thereby impairing antiviral innate immune responses to HSV-1 and VSV.","method":"GSNOR KO MEFs and macrophages, viral replication assays, S-nitrosylation site identification, Gsnor-/- mouse infection model","journal":"Redox biology","confidence":"High","confidence_rationale":"Tier 2 — KO with defined S-nitrosylation site and functional kinase activity assay","pmids":["34678655"],"is_preprint":false},{"year":2021,"finding":"ADH5-maintained SNO homeostasis facilitates STING activation; GSNO induces S-nitrosylation of STING at Cys257, inhibiting its binding to cGAMP; ADH5 metabolizes GSNO to prevent this inhibitory S-nitrosylation, thereby licensing STING-dependent innate immunity against HSV-1 and Listeria.","method":"Adh5 KO mice, S-nitrosylation site mapping (Cys257 of STING), cGAMP binding assay, viral and bacterial infection models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — KO genetics, defined S-nitrosylation site, biochemical binding assay, multiple pathogen models","pmids":["38409248"],"is_preprint":false},{"year":2022,"finding":"GSNOR deficiency leads to CDK5 S-nitrosylation at Cys83, inhibiting CDK5 kinase activity and CDK5-mediated autophagy, and attenuating MPTP-induced dopaminergic neuron loss in a Parkinson's disease mouse model.","method":"GSNOR KO mice, MPTP model, GSNOR inhibitor N6022, S-nitrosylation site identification, CDK5 kinase activity assay","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 — KO and pharmacological inhibition with defined S-nitrosylation site and kinase activity readout","pmids":["35918012"],"is_preprint":false},{"year":2023,"finding":"GSNOR is localized in mitochondria (in addition to cytoplasm); mitochondrial GSNOR denitrosylates ANT1 at Cys160, preventing mitochondrial dysfunction; cardiac-specific GSNOR KO worsens pressure-overload heart failure; restoring mitochondrial GSNOR or expressing non-nitrosylatable ANT1 C160A improves mitochondrial function and cardiac performance.","method":"Cellular fractionation, immunofluorescence, colloidal gold staining, cardiac-specific KO mice, AAV9-mediated mitochondria-targeted GSNOR overexpression, biotin-switch/LC-MS/MS for S-nitrosylation site identification, ANT1 C160A mutagenesis","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1–2 — novel subcellular localization confirmed by multiple methods, mutagenesis of modification site, KO phenotype, rescue experiment","pmids":["37377022"],"is_preprint":false},{"year":2023,"finding":"GSNOR deficiency induces S-nitrosylation of focal adhesion kinase 1 (FAK1) at Cys658, enhancing FAK1 autophosphorylation and providing cancer cells with anoikis resistance; GSNOR-deficient tumors are sensitive to FAK1 inhibitors.","method":"Multiple tumor models, S-nitrosylation site mapping (C658), FAK1 kinase activity assay, pharmacological FAK1 inhibitors, GSNOR KO","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — defined S-nitrosylation site with functional kinase assay, multiple tumor models","pmids":["36656716"],"is_preprint":false},{"year":2024,"finding":"GSNOR deficiency leads to S-nitrosylation of MAPK14 (p38) at Cys211, augmenting MAPK14 kinase activity and promoting NLRP3 and IL-1β transcription; GSNOR-/-Nlrp3-/- double KO mice show reduced severity of LPS-induced septic shock and DSS-induced colitis.","method":"GSNOR KO macrophages, double KO mice, S-nitrosylation site identification, MAPK14 kinase activity assay, in vivo disease models","journal":"Cellular & molecular immunology","confidence":"High","confidence_rationale":"Tier 2 — defined S-nitrosylation site with kinase activity, genetic epistasis in two disease models","pmids":["38570588"],"is_preprint":false},{"year":2025,"finding":"NEDD4 E3 ubiquitin ligase ubiquitinates GSNOR, targeting it for proteasomal degradation during cardiac hypertrophy; NEDD4 enzyme-dead mutant and non-ubiquitylatable GSNOR mutant decrease GSNOR ubiquitination and inhibit hypertrophic growth; cardiac-specific NEDD4 deficiency inhibits hypertrophy.","method":"Mass spectrometry for ubiquitin ligase identification, NEDD4 cardiomyocyte-specific KO mice, enzyme-dead NEDD4 mutant, GSNOR non-ubiquitylatable mutant, NEDD4 inhibitor (IBM)","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — identified E3 ligase by MS, mutagenesis of ubiquitination sites, conditional KO phenotype","pmids":["39846173"],"is_preprint":false},{"year":2014,"finding":"NF-κB binds an essential responsive sequence (−88 to −73 bp) in the GSNOR promoter in response to NGF/TrkA/MEK1/2 signaling to activate GSNOR transcription; GSNOR overexpression suppresses NGF-induced PC12 neurite outgrowth, while GSNOR knockdown promotes differentiation.","method":"Luciferase reporter assay, EMSA, ChIP, pharmacological inhibition of TrkA and MEK1/2, GSNOR overexpression and knockdown","journal":"Free radical research","confidence":"High","confidence_rationale":"Tier 2 — EMSA, ChIP, and reporter assays combined with gain/loss-of-function in PC12 cells","pmids":["24654711"],"is_preprint":false}],"current_model":"ADH5/GSNOR is a cytoplasmic (and mitochondrial) denitrosylase that catalyzes NADH-dependent reduction of GSNO (and S-hydroxymethylglutathione/formaldehyde-GSH adduct), thereby controlling intracellular protein S-nitrosylation; it directly denitrosylates specific substrates (ANT1, AGT, CaMKIIα, TBK1, STING, FAK1, Akt, CDK5, MAPK14) at defined cysteines to regulate their activity, and its own activity and abundance are regulated by S-nitrosation of conserved cysteines (autoinhibitory feedback), allosteric GSNO binding, ATM-CHK2-p53-dependent translational induction under oxidative stress, and NEDD4-mediated ubiquitin-proteasomal degradation; transcription is driven by Sp1 (repressed by Sp3/Sp4 and FBI-1) and induced by NF-κB and HSF1 in specific cellular contexts."},"narrative":{"teleology":[{"year":1984,"claim":"Establishing the gene identity: ADH5 was shown to encode a dimeric formaldehyde dehydrogenase mapped to chromosome 4, providing the first molecular characterization of the enzyme later recognized as GSNOR.","evidence":"Biochemical isozyme analysis and somatic cell hybrid mapping","pmids":["6467984"],"confidence":"Medium","gaps":["Single study; protein structure and catalytic mechanism unresolved","Substrate specificity beyond formaldehyde-GSH adduct not yet explored"]},{"year":1992,"claim":"Defining the gene structure and housekeeping expression: the ADH5 gene was shown to comprise nine exons with a CpG-island promoter lacking TATA/CAAT boxes, explaining its ubiquitous expression.","evidence":"Genomic cloning, primer extension, CAT reporter assay","pmids":["1446828"],"confidence":"High","gaps":["Transcription factor binding not yet defined","No functional link to NO metabolism established"]},{"year":1999,"claim":"Identifying the core transcriptional machinery: Sp1 was established as the principal activator of ADH5 transcription through two cis-elements near the start site, with Sp3/Sp4 acting as competitive repressors—revealing how ubiquitous yet tunable expression is achieved.","evidence":"Mutagenesis of cis-elements, reporter assays in Sp1-null Drosophila SL2 cells, EMSA","pmids":["9867805"],"confidence":"High","gaps":["Signal-responsive transcriptional regulation not yet addressed","No post-translational regulatory mechanism known"]},{"year":2002,"claim":"Revealing promoter fine-tuning: the POZ-domain factor FBI-1 was shown to repress ADH5 transcription by binding upstream of the Sp1 sites and disrupting Sp1–DNA interaction, adding a repressive layer to ADH5 regulation.","evidence":"EMSA, ChIP, GST pull-down, DNase I footprinting, reporter assay","pmids":["12004059"],"confidence":"High","gaps":["Physiological context for FBI-1-mediated repression unclear","No connection to NO signaling yet"]},{"year":2010,"claim":"Linking GSNOR to cancer via denitrosylation of a DNA repair protein: GSNOR deficiency was shown to cause iNOS-dependent S-nitrosylation and proteasomal degradation of AGT, impairing O⁶-alkylguanine repair and promoting hepatocellular carcinoma—the first demonstration that GSNOR protects genome integrity through substrate-specific denitrosylation.","evidence":"GSNOR KO mice, carcinogen challenge, biochemical AGT quantification, epistasis with iNOS KO","pmids":["20371487"],"confidence":"High","gaps":["Direct S-nitrosylation site on AGT not mapped","Mechanism of nitrosylation-induced AGT degradation not fully defined"]},{"year":2011,"claim":"Resolving the cell-autonomous origin of GSNOR's tumor-suppressive role: hepatocyte-specific, but not hematopoietic-lineage, GSNOR deletion recapitulated AGT depletion and genotoxic sensitivity, demonstrating that the protective function is intrinsic to the parenchymal cell.","evidence":"Conditional cell-type-specific KO mice, γH2AX staining, iNOS epistasis","pmids":["21385828"],"confidence":"High","gaps":["Full spectrum of hepatocyte S-nitrosoproteome changes not catalogued"]},{"year":2014,"claim":"Discovering signal-responsive transcriptional induction: NF-κB was shown to bind the GSNOR promoter and activate transcription in response to NGF/TrkA/MEK signaling, while GSNOR overexpression suppressed neurite outgrowth—linking GSNOR transcription to differentiation signaling.","evidence":"Luciferase reporter, EMSA, ChIP, pharmacological inhibition, gain/loss-of-function in PC12 cells","pmids":["24654711"],"confidence":"High","gaps":["Whether NF-κB regulation is generalizable beyond NGF/PC12 context unclear","Direct NOS isoform involvement in neurite outgrowth not tested"]},{"year":2016,"claim":"Revealing autoinhibitory feedback: S-nitrosation of GSNOR's own non-zinc cysteines was shown to inhibit enzyme activity with allosteric conformational changes near the active site—establishing a product-feedback mechanism that limits GSNOR activity under high nitrosative stress.","evidence":"In vitro enzyme assay, mass spectrometry, HDX-MS, site-directed cysteine mutagenesis","pmids":["27064847"],"confidence":"High","gaps":["Physiological relevance of GSNOR self-nitrosation in vivo not demonstrated","Identity of specific inhibitory cysteines in vivo not fully resolved"]},{"year":2017,"claim":"Extending GSNOR function to synaptic plasticity and aging: age-dependent GSNOR upregulation was shown to reduce CaMKIIα S-nitrosylation at C280/C289, impairing synaptosomal CaMKIIα accumulation and LTP, while GSNOR KO rescued age-related cognitive decline.","evidence":"GSNOR transgenic and KO mice, Morris water maze, LTP recording, CaMKIIα site-directed mutagenesis","pmids":["28883020"],"confidence":"High","gaps":["Whether direct GSNOR–CaMKIIα interaction occurs is unknown","Upstream signal driving age-dependent GSNOR induction not identified"]},{"year":2019,"claim":"Uncovering allosteric activation by substrate: GSNOR kinetics showed non-hyperbolic (cooperative) behavior with GSNO; mutagenesis of Lys188 and Lys323 at a distinct allosteric site abolished cooperativity—revealing a feed-forward mechanism that accelerates GSNO clearance at rising concentrations.","evidence":"Enzyme kinetics, HDX-MS, molecular docking, site-directed mutagenesis (K188A, K323A)","pmids":["31766125"],"confidence":"High","gaps":["Crystal structure of GSNO-bound allosteric site not obtained","Physiological GSNO concentration dynamics in vivo not measured"]},{"year":2020,"claim":"Connecting ADH5 to a Mendelian disease: digenic ADH5/ALDH2 loss was shown to cause AMeD syndrome through toxic formaldehyde accumulation that damages DNA and exhausts hematopoietic stem cells, with an Adh5-E506K knockin mouse recapitulating the phenotype.","evidence":"Patient exome sequencing, formaldehyde tolerance assays, mouse knockin model, hematopoietic differentiation","pmids":["33355142"],"confidence":"High","gaps":["Relative contribution of GSNO denitrosylase vs. formaldehyde dehydrogenase activity to disease unclear","Tissue-specific vulnerability beyond hematopoietic system not fully explored"]},{"year":2020,"claim":"Identifying oxidative-stress-responsive translational regulation: hydrogen peroxide and mitochondrial ROS were shown to induce GSNOR protein via ATM→CHK2→p53 signaling at the translational level, coupling GSNOR abundance to the cellular redox state and sustaining mitophagy.","evidence":"Pharmacological inhibitors, siRNA, redox-insensitive ATM mutant, mitophagy assays","pmids":["33245190"],"confidence":"High","gaps":["Translational mechanism (IRES, uORF, etc.) not defined","Whether this regulation operates in vivo not established"]},{"year":2020,"claim":"Linking ADH5 to thermogenesis: BAT-specific ADH5 KO impaired cold-induced UCP1-dependent thermogenesis, and HSF1 was identified as an ADH5 transcriptional inducer in this tissue, connecting NO homeostasis to metabolic adaptation.","evidence":"BAT-specific KO mice, cold exposure, UCP1 S-nitrosylation measurement, HSF1 activator treatment","pmids":["34788615"],"confidence":"High","gaps":["Direct HSF1 binding site on ADH5 promoter not mapped","UCP1 S-nitrosylation site not identified"]},{"year":2021,"claim":"Defining GSNOR's role in antiviral innate immunity: GSNOR deficiency increased S-nitrosylation of TBK1 at Cys423 (inhibiting its kinase activity and interferon production) and of STING at Cys257 (blocking cGAMP binding), establishing GSNOR as a prerequisite for effective cGAS-STING and TBK1 signaling.","evidence":"GSNOR KO MEFs/macrophages, viral replication assays, S-nitrosylation site mapping, cGAMP binding assay, in vivo infection models","pmids":["34678655","38409248"],"confidence":"High","gaps":["Whether GSNOR directly denitrosylates TBK1/STING or acts only via GSNO clearance is unclear","Relative contribution of TBK1 vs. STING nitrosylation to immune phenotype not dissected"]},{"year":2022,"claim":"Extending denitrosylation targets to neurodegeneration: GSNOR deficiency was shown to S-nitrosylate CDK5 at Cys83, inhibiting CDK5 kinase activity and autophagy, and attenuating MPTP-induced dopaminergic neuron loss—positioning GSNOR as a modulator of Parkinson's disease pathology.","evidence":"GSNOR KO mice, MPTP model, GSNOR inhibitor N6022, S-nitrosylation site identification, CDK5 kinase assay","pmids":["35918012"],"confidence":"High","gaps":["Whether CDK5 inhibition is neuroprotective or neurotoxic in long-term models not resolved","Effect of GSNOR inhibition on broader SNO-proteome in brain not profiled"]},{"year":2023,"claim":"Discovering mitochondrial localization and a cardiac-protective denitrosylation target: GSNOR was found in mitochondria where it denitrosylates ANT1 at Cys160; cardiac-specific GSNOR KO worsened heart failure, while mitochondria-targeted GSNOR or ANT1-C160A rescued mitochondrial and cardiac function.","evidence":"Cellular fractionation, immunofluorescence, colloidal gold staining, cardiac-specific KO, AAV9-mitochondrial GSNOR, ANT1 C160A mutagenesis, LC-MS/MS","pmids":["37377022"],"confidence":"High","gaps":["Mitochondrial import mechanism for GSNOR not identified","Breadth of mitochondrial SNO targets beyond ANT1 unknown"]},{"year":2023,"claim":"Linking GSNOR loss to anoikis resistance in cancer: GSNOR deficiency was shown to S-nitrosylate FAK1 at Cys658, enhancing FAK1 autophosphorylation and conferring anoikis resistance; GSNOR-deficient tumors were sensitive to FAK1 inhibitors.","evidence":"Multiple tumor models, S-nitrosylation site mapping, FAK1 kinase assay, pharmacological FAK1 inhibition","pmids":["36656716"],"confidence":"High","gaps":["Whether FAK1 S-nitrosylation drives metastasis in vivo not tested","Therapeutic window for FAK inhibition in GSNOR-low tumors not defined"]},{"year":2024,"claim":"Revealing a pro-inflammatory consequence of GSNOR loss: GSNOR deficiency S-nitrosylated MAPK14 at Cys211, augmenting its kinase activity and driving NLRP3 inflammasome transcription; double KO with Nlrp3 rescued sepsis and colitis severity.","evidence":"GSNOR KO macrophages, double KO mice, S-nitrosylation site ID, MAPK14 kinase assay, LPS sepsis and DSS colitis models","pmids":["38570588"],"confidence":"High","gaps":["Whether MAPK14 Cys211 nitrosylation occurs in human inflammatory disease not shown","Role of other MAPKs as GSNOR targets not assessed"]},{"year":2025,"claim":"Identifying the E3 ligase controlling GSNOR turnover: NEDD4 was shown to ubiquitinate GSNOR and target it for proteasomal degradation during cardiac hypertrophy; enzyme-dead NEDD4 or non-ubiquitylatable GSNOR mutant blocked this degradation and inhibited hypertrophy.","evidence":"Mass spectrometry for E3 ligase identification, cardiomyocyte-specific NEDD4 KO, enzyme-dead mutant, non-ubiquitylatable GSNOR mutant","pmids":["39846173"],"confidence":"High","gaps":["Specific ubiquitination sites on GSNOR not mapped","Whether NEDD4-GSNOR axis operates outside cardiac tissue unknown"]},{"year":null,"claim":"Key unresolved questions include: the structural basis for substrate selectivity among diverse S-nitrosylated targets; the mechanism of GSNOR import into mitochondria; how the balance between GSNOR's denitrosylase and formaldehyde dehydrogenase activities is regulated in different tissues; and whether pharmacological GSNOR modulation can be therapeutically exploited in cancer, neurodegeneration, and heart failure.","evidence":"Open questions derived from current literature","pmids":[],"confidence":"Low","gaps":["No crystal structure of GSNOR bound to a protein S-nitrosylation substrate","Mitochondrial targeting signal or import mechanism unknown","No clinical trials of GSNOR-targeted therapy reported"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,10,11,14]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,12,13,20,21,22,23,24,25]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11,23]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[23]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[5,7,8,16,19]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[20,21,25]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[13,24,27]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[24]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,8,16]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[10,17]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[11,18]}],"complexes":[],"partners":["AGT","CAMK2A","TBK1","STING1","FAK1","AKT1","CDK5","NEDD4"],"other_free_text":[]},"mechanistic_narrative":"ADH5 (GSNOR/FDH) is a ubiquitously expressed, NAD⁺/NADH-dependent oxidoreductase that serves dual roles as the principal enzyme metabolizing S-nitrosoglutathione (GSNO) to control protein S-nitrosylation and as the primary cytoplasmic (and mitochondrial) formaldehyde dehydrogenase that detoxifies endogenous formaldehyde via its glutathione adduct S-hydroxymethylglutathione [PMID:28393572, PMID:37377022]. Through GSNO catabolism, ADH5 denitrosylates a growing roster of substrates at defined cysteines—including AGT, CaMKIIα, TBK1, STING, FAK1, Akt, CDK5, MAPK14, and ANT1—thereby calibrating DNA repair, innate immunity, kinase signaling, synaptic plasticity, and mitochondrial integrity [PMID:20371487, PMID:28883020, PMID:34678655, PMID:38409248, PMID:36656716, PMID:35918012, PMID:38570588, PMID:37377022, PMID:29860106]. ADH5 activity is itself regulated by product-feedback S-nitrosation of non-zinc cysteines, allosteric activation by GSNO, ATM–CHK2–p53-dependent translational induction under oxidative stress, NEDD4-mediated ubiquitin-proteasomal degradation, and transcriptional control by Sp1 (opposed by Sp3/Sp4 and FBI-1), NF-κB, and HSF1 [PMID:27064847, PMID:31766125, PMID:33245190, PMID:39846173, PMID:9867805, PMID:12004059, PMID:24654711, PMID:34788615]. Digenic loss of ADH5 and ALDH2 causes AMeD syndrome (aplastic anemia, mental retardation, dwarfism) through toxic formaldehyde accumulation and hematopoietic stem cell failure [PMID:33355142, PMID:33512438]."},"prefetch_data":{"uniprot":{"accession":"P11766","full_name":"Alcohol dehydrogenase class-3","aliases":["Alcohol dehydrogenase 5","Alcohol dehydrogenase class chi chain","Alcohol dehydrogenase class-III","Glutathione-dependent formaldehyde dehydrogenase","FALDH","FDH","GSH-FDH","S-(hydroxymethyl)glutathione dehydrogenase"],"length_aa":374,"mass_kda":39.7,"function":"Catalyzes the oxidation of long-chain primary alcohols and the oxidation of S-(hydroxymethyl) glutathione (PubMed:8460164). Also oxidizes long chain omega-hydroxy fatty acids, such as 20-HETE, producing both the intermediate aldehyde, 20-oxoarachidonate and the end product, a dicarboxylic acid, (5Z,8Z,11Z,14Z)-eicosatetraenedioate (PubMed:16081420). Class-III ADH is remarkably ineffective in oxidizing ethanol (PubMed:8460164). Required for clearance of cellular formaldehyde, a cytotoxic and carcinogenic metabolite that induces DNA damage (PubMed:33355142). Also acts as a S-nitroso-glutathione reductase by catalyzing the NADH-dependent reduction of S-nitrosoglutathione, thereby regulating protein S-nitrosylation (By similarity)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P11766/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADH5","classification":"Not Classified","n_dependent_lines":40,"n_total_lines":1208,"dependency_fraction":0.033112582781456956},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CAPZB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ADH5","total_profiled":1310},"omim":[{"mim_id":"619151","title":"AMED SYNDROME, DIGENIC; AMEDS","url":"https://www.omim.org/entry/619151"},{"mim_id":"614675","title":"BONE MARROW FAILURE SYNDROME 1; BMFS1","url":"https://www.omim.org/entry/614675"},{"mim_id":"600086","title":"ALCOHOL DEHYDROGENASE 7; ADH7","url":"https://www.omim.org/entry/600086"},{"mim_id":"103780","title":"ALCOHOL DEPENDENCE","url":"https://www.omim.org/entry/103780"},{"mim_id":"103740","title":"ALCOHOL DEHYDROGENASE 4; ADH4","url":"https://www.omim.org/entry/103740"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ADH5"},"hgnc":{"alias_symbol":["ADH-3","ADHX","GSNOR"],"prev_symbol":["FDH"]},"alphafold":{"accession":"P11766","domains":[{"cath_id":"3.40.50.720","chopping":"180-319","consensus_level":"high","plddt":98.2897,"start":180,"end":319}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11766","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11766-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11766-F1-predicted_aligned_error_v6.png","plddt_mean":98.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADH5","jax_strain_url":"https://www.jax.org/strain/search?query=ADH5"},"sequence":{"accession":"P11766","fasta_url":"https://rest.uniprot.org/uniprotkb/P11766.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11766/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11766"}},"corpus_meta":[{"pmid":"20371487","id":"PMC_20371487","title":"S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis.","date":"2010","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20371487","citation_count":122,"is_preprint":false},{"pmid":"28393572","id":"PMC_28393572","title":"The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.","date":"2017","source":"Critical reviews in biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28393572","citation_count":111,"is_preprint":false},{"pmid":"21543898","id":"PMC_21543898","title":"Function of S-nitrosoglutathione reductase (GSNOR) in plant development and under biotic/abiotic stress.","date":"2011","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/21543898","citation_count":107,"is_preprint":false},{"pmid":"9867805","id":"PMC_9867805","title":"Sp3 and Sp4 can repress transcription by competing with Sp1 for the core cis-elements on the human ADH5/FDH minimal promoter.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9867805","citation_count":99,"is_preprint":false},{"pmid":"27064847","id":"PMC_27064847","title":"S-Nitrosation of Conserved Cysteines Modulates Activity and Stability of S-Nitrosoglutathione Reductase (GSNOR).","date":"2016","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27064847","citation_count":88,"is_preprint":false},{"pmid":"21893250","id":"PMC_21893250","title":"GSNOR-mediated de-nitrosylation in the plant defence response.","date":"2011","source":"Plant science : an international journal of experimental plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/21893250","citation_count":88,"is_preprint":false},{"pmid":"23288904","id":"PMC_23288904","title":"S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23288904","citation_count":86,"is_preprint":false},{"pmid":"18848533","id":"PMC_18848533","title":"FDH: an aldehyde dehydrogenase fusion enzyme in folate metabolism.","date":"2008","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/18848533","citation_count":83,"is_preprint":false},{"pmid":"12004059","id":"PMC_12004059","title":"POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12004059","citation_count":83,"is_preprint":false},{"pmid":"2208651","id":"PMC_2208651","title":"Improved methods for genotype determination of human alcohol dehydrogenase (ADH) at ADH 2 and ADH 3 loci by using polymerase chain reaction-directed mutagenesis.","date":"1990","source":"Clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2208651","citation_count":80,"is_preprint":false},{"pmid":"33355142","id":"PMC_33355142","title":"Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/33355142","citation_count":70,"is_preprint":false},{"pmid":"31467270","id":"PMC_31467270","title":"GSNOR provides plant tolerance to iron toxicity via preventing iron-dependent nitrosative and oxidative cytotoxicity.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31467270","citation_count":70,"is_preprint":false},{"pmid":"518534","id":"PMC_518534","title":"Genetics and ontogeny of alcohol dehydrogenase isozymes in the mouse: evidence for a cis-acting regulator gene (Adt-i) controlling C2 isozyme expression in reproductive tissues and close linkage of Adh-3 and Adt-i on chromosome 3.","date":"1979","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/518534","citation_count":60,"is_preprint":false},{"pmid":"21622839","id":"PMC_21622839","title":"S-Nitrosoglutathione reductase (GSNOR) mediates the biosynthesis of jasmonic acid and ethylene induced by feeding of the insect herbivore Manduca sexta and is important for jasmonate-elicited responses in Nicotiana attenuata.","date":"2011","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/21622839","citation_count":50,"is_preprint":false},{"pmid":"19514054","id":"PMC_19514054","title":"Genetic variants of GSNOR and ADRB2 influence response to albuterol in African-American children with severe asthma.","date":"2009","source":"Pediatric pulmonology","url":"https://pubmed.ncbi.nlm.nih.gov/19514054","citation_count":50,"is_preprint":false},{"pmid":"33004257","id":"PMC_33004257","title":"The Emerging Role of GSNOR in Oxidative Stress Regulation.","date":"2020","source":"Trends in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/33004257","citation_count":49,"is_preprint":false},{"pmid":"33245190","id":"PMC_33245190","title":"Redox activation of ATM enhances GSNOR translation to sustain mitophagy and tolerance to oxidative stress.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/33245190","citation_count":49,"is_preprint":false},{"pmid":"25803130","id":"PMC_25803130","title":"Sulfido and cysteine ligation changes at the molybdenum cofactor during substrate conversion by formate dehydrogenase (FDH) from Rhodobacter capsulatus.","date":"2015","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25803130","citation_count":49,"is_preprint":false},{"pmid":"1446828","id":"PMC_1446828","title":"Cloning and characterization of the ADH5 gene encoding human alcohol dehydrogenase 5, formaldehyde dehydrogenase.","date":"1992","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/1446828","citation_count":46,"is_preprint":false},{"pmid":"37377022","id":"PMC_37377022","title":"Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation.","date":"2023","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/37377022","citation_count":45,"is_preprint":false},{"pmid":"33962063","id":"PMC_33962063","title":"Redox sensor QSOX1 regulates plant immunity by targeting GSNOR to modulate ROS generation.","date":"2021","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/33962063","citation_count":45,"is_preprint":false},{"pmid":"28039071","id":"PMC_28039071","title":"S-nitrosoglutathione reductase (GSNOR) activity is down-regulated during pepper (Capsicum annuum L.) fruit ripening.","date":"2016","source":"Nitric oxide : biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28039071","citation_count":43,"is_preprint":false},{"pmid":"28533171","id":"PMC_28533171","title":"Chronicles of a reductase: Biochemistry, genetics and physio-pathological role of GSNOR.","date":"2017","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28533171","citation_count":42,"is_preprint":false},{"pmid":"21385828","id":"PMC_21385828","title":"Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine.","date":"2011","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/21385828","citation_count":42,"is_preprint":false},{"pmid":"26232921","id":"PMC_26232921","title":"Quantitative proteomics analysis reveals that S-nitrosoglutathione reductase (GSNOR) and nitric oxide signaling enhance poplar defense against chilling stress.","date":"2015","source":"Planta","url":"https://pubmed.ncbi.nlm.nih.gov/26232921","citation_count":40,"is_preprint":false},{"pmid":"23440427","id":"PMC_23440427","title":"Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/23440427","citation_count":37,"is_preprint":false},{"pmid":"604164","id":"PMC_604164","title":"The genetics of alpha-hydroxyacid oxidase and alcohol dehydrogenase in the mouse: evidence for multiple gene loci and linkage between Hao-2 and Adh-3.","date":"1977","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/604164","citation_count":37,"is_preprint":false},{"pmid":"28883020","id":"PMC_28883020","title":"Increased GSNOR Expression during Aging Impairs Cognitive Function and Decreases S-Nitrosation of CaMKIIα.","date":"2017","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28883020","citation_count":36,"is_preprint":false},{"pmid":"16321049","id":"PMC_16321049","title":"Deactivation of formate dehydrogenase (FDH) in solution and at gas-liquid interfaces.","date":"2005","source":"Biotechnology progress","url":"https://pubmed.ncbi.nlm.nih.gov/16321049","citation_count":33,"is_preprint":false},{"pmid":"33512438","id":"PMC_33512438","title":"Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33512438","citation_count":31,"is_preprint":false},{"pmid":"32514323","id":"PMC_32514323","title":"The failure of two major formaldehyde catabolism enzymes (ADH5 and ALDH2) leads to partial synthetic lethality in C57BL/6 mice.","date":"2020","source":"Genes and environment : the official journal of the Japanese Environmental Mutagen Society","url":"https://pubmed.ncbi.nlm.nih.gov/32514323","citation_count":31,"is_preprint":false},{"pmid":"9359603","id":"PMC_9359603","title":"Folate and 10-formyltetrahydrofolate dehydrogenase (FDH) expression in the central nervous system of the mature rat.","date":"1997","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9359603","citation_count":30,"is_preprint":false},{"pmid":"34956283","id":"PMC_34956283","title":"Quantitative Proteome Profiling of a S-Nitrosoglutathione Reductase (GSNOR) Null Mutant Reveals a New Class of Enzymes Involved in Nitric Oxide Homeostasis in Plants.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/34956283","citation_count":27,"is_preprint":false},{"pmid":"29860106","id":"PMC_29860106","title":"GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation.","date":"2018","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/29860106","citation_count":26,"is_preprint":false},{"pmid":"30029585","id":"PMC_30029585","title":"Denitrosylate and live longer: how ADH5/GSNOR links mitophagy to aging.","date":"2018","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30029585","citation_count":24,"is_preprint":false},{"pmid":"16712799","id":"PMC_16712799","title":"Leucovorin-induced resistance against FDH growth suppressor effects occurs through DHFR up-regulation.","date":"2006","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16712799","citation_count":22,"is_preprint":false},{"pmid":"38574838","id":"PMC_38574838","title":"N6022 attenuates cerebral ischemia/reperfusion injury-induced microglia ferroptosis by promoting Nrf2 nuclear translocation and inhibiting the GSNOR/GSTP1 axis.","date":"2024","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38574838","citation_count":20,"is_preprint":false},{"pmid":"29694854","id":"PMC_29694854","title":"S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.","date":"2018","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29694854","citation_count":19,"is_preprint":false},{"pmid":"34788615","id":"PMC_34788615","title":"ADH5-mediated NO bioactivity maintains metabolic homeostasis in brown adipose tissue.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34788615","citation_count":19,"is_preprint":false},{"pmid":"37572458","id":"PMC_37572458","title":"FDH/Hases-S-chain mediated electron redistributing in Citrobacter freundii JH@FeS during degradation of sulfamethoxazole and nitrate.","date":"2023","source":"Water research","url":"https://pubmed.ncbi.nlm.nih.gov/37572458","citation_count":18,"is_preprint":false},{"pmid":"16597835","id":"PMC_16597835","title":"Modular organization of FDH: Exploring the basis of hydrolase catalysis.","date":"2006","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/16597835","citation_count":18,"is_preprint":false},{"pmid":"11306061","id":"PMC_11306061","title":"Mammalian alcohol dehydrogenase of higher classes: analyses of human ADH5 and rat ADH6.","date":"2001","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/11306061","citation_count":18,"is_preprint":false},{"pmid":"34678655","id":"PMC_34678655","title":"GSNOR facilitates antiviral innate immunity by restricting TBK1 cysteine S-nitrosation.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34678655","citation_count":18,"is_preprint":false},{"pmid":"20932929","id":"PMC_20932929","title":"Nitric oxide metabolism controlled by formaldehyde dehydrogenase (fdh, homolog of mammalian GSNOR) plays a crucial role in visual pattern memory in Drosophila.","date":"2010","source":"Nitric oxide : biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20932929","citation_count":17,"is_preprint":false},{"pmid":"23475631","id":"PMC_23475631","title":"Improvement of ethanol productivity and energy efficiency by degradation of inhibitors using recombinant Zymomonas mobilis (pHW20a-fdh).","date":"2013","source":"Biotechnology and bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/23475631","citation_count":17,"is_preprint":false},{"pmid":"35017648","id":"PMC_35017648","title":"GSNOR regulates ganoderic acid content in Ganoderma lucidum under heat stress through S-nitrosylation of catalase.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35017648","citation_count":17,"is_preprint":false},{"pmid":"21332622","id":"PMC_21332622","title":"Transcription of fdh and hyd in Syntrophobacter spp. and Methanospirillum spp. as a diagnostic tool for monitoring anaerobic sludge deprived of molybdenum, tungsten and selenium.","date":"2011","source":"Environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/21332622","citation_count":17,"is_preprint":false},{"pmid":"32112881","id":"PMC_32112881","title":"Mitophagy contributes to alpha-tocopheryl succinate toxicity in GSNOR-deficient hepatocellular carcinoma.","date":"2020","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32112881","citation_count":16,"is_preprint":false},{"pmid":"29431087","id":"PMC_29431087","title":"Tumor Suppressor Roles of the Denitrosylase GSNOR.","date":"2016","source":"Critical reviews in oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/29431087","citation_count":16,"is_preprint":false},{"pmid":"34356361","id":"PMC_34356361","title":"GSNOR Contributes to Demethylation and Expression of Transposable Elements and Stress-Responsive Genes.","date":"2021","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34356361","citation_count":16,"is_preprint":false},{"pmid":"1362387","id":"PMC_1362387","title":"Alcohol dehydrogenase genes: restriction fragment length polymorphisms for ADH4 (pi-ADH) and ADH5 (chi-ADH) and construction of haplotypes among different ADH classes.","date":"1992","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1362387","citation_count":16,"is_preprint":false},{"pmid":"22164338","id":"PMC_22164338","title":"Dose-Dependent Change in Elimination Kinetics of Ethanol due to Shift of Dominant Metabolizing Enzyme from ADH 1 (Class I) to ADH 3 (Class III) in Mouse.","date":"2011","source":"International journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/22164338","citation_count":16,"is_preprint":false},{"pmid":"18031276","id":"PMC_18031276","title":"Protein engineering applications of industrially exploitable enzymes: Geobacillus stearothermophilus LDH and Candida methylica FDH.","date":"2007","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/18031276","citation_count":15,"is_preprint":false},{"pmid":"31043586","id":"PMC_31043586","title":"nNOS/GSNOR interaction contributes to skeletal muscle differentiation and homeostasis.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31043586","citation_count":15,"is_preprint":false},{"pmid":"23355119","id":"PMC_23355119","title":"The influence of genetic polymorphisms in XRCC3 and ADH5 genes on the frequency of genotoxicity biomarkers in workers exposed to formaldehyde.","date":"2013","source":"Environmental and molecular mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23355119","citation_count":15,"is_preprint":false},{"pmid":"39846173","id":"PMC_39846173","title":"NEDD4-Mediated GSNOR Degradation Aggravates Cardiac Hypertrophy and Dysfunction.","date":"2025","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/39846173","citation_count":14,"is_preprint":false},{"pmid":"36252109","id":"PMC_36252109","title":"Arginase-1 Deletion in Erythrocytes Promotes Vascular Calcification via Enhanced GSNOR (S-Nitrosoglutathione Reductase) Expression and NO Signaling in Smooth Muscle Cells.","date":"2022","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36252109","citation_count":14,"is_preprint":false},{"pmid":"35640428","id":"PMC_35640428","title":"GABA keeps nitric oxide in balance by regulating GSNOR to enhance disease resistance of harvested tomato against Botrytis cinerea.","date":"2022","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35640428","citation_count":13,"is_preprint":false},{"pmid":"38409248","id":"PMC_38409248","title":"S-nitrosothiol homeostasis maintained by ADH5 facilitates STING-dependent host defense against pathogens.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38409248","citation_count":12,"is_preprint":false},{"pmid":"33621575","id":"PMC_33621575","title":"Synthesis and characterization of ordered mesoporous silicas for the immobilization of formate dehydrogenase (FDH).","date":"2021","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33621575","citation_count":12,"is_preprint":false},{"pmid":"11095947","id":"PMC_11095947","title":"Human class V alcohol dehydrogenase (ADH5): A complex transcription unit generates C-terminal multiplicity.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11095947","citation_count":12,"is_preprint":false},{"pmid":"6467984","id":"PMC_6467984","title":"Human formaldehyde dehydrogenase (FDH) and its assignment to chromosome 4.","date":"1984","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/6467984","citation_count":11,"is_preprint":false},{"pmid":"23159888","id":"PMC_23159888","title":"Analysis of mammalian alcohol dehydrogenase 5 (ADH5): characterisation of rat ADH5 with comparisons to the corresponding human variant.","date":"2012","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/23159888","citation_count":11,"is_preprint":false},{"pmid":"36656716","id":"PMC_36656716","title":"GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylation.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36656716","citation_count":10,"is_preprint":false},{"pmid":"31030612","id":"PMC_31030612","title":"Tailoring of recombinant FDH: effect of histidine tag location on solubility and catalytic properties of Chaetomium thermophilum formate dehydrogenase (CtFDH).","date":"2019","source":"Preparative biochemistry & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31030612","citation_count":10,"is_preprint":false},{"pmid":"27387009","id":"PMC_27387009","title":"What's My Substrate? Computational Function Assignment of Candida parapsilosis ADH5 by Genome Database Search, Virtual Screening, and QM/MM Calculations.","date":"2016","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/27387009","citation_count":10,"is_preprint":false},{"pmid":"27904073","id":"PMC_27904073","title":"A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH).","date":"2016","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/27904073","citation_count":10,"is_preprint":false},{"pmid":"35918012","id":"PMC_35918012","title":"GSNOR deficiency attenuates MPTP-induced neurotoxicity and autophagy by facilitating CDK5 S-nitrosation in a mouse model of Parkinson's disease.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35918012","citation_count":9,"is_preprint":false},{"pmid":"33266126","id":"PMC_33266126","title":"The Physiological Implications of S-Nitrosoglutathione Reductase (GSNOR) Activity Mediating NO Signalling in Plant Root Structures.","date":"2020","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33266126","citation_count":9,"is_preprint":false},{"pmid":"32423672","id":"PMC_32423672","title":"High-level heterologous expression of active Chaetomium thermophilum FDH in Pichia pastoris.","date":"2020","source":"Enzyme and microbial technology","url":"https://pubmed.ncbi.nlm.nih.gov/32423672","citation_count":9,"is_preprint":false},{"pmid":"38549378","id":"PMC_38549378","title":"GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness.","date":"2024","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/38549378","citation_count":8,"is_preprint":false},{"pmid":"35039546","id":"PMC_35039546","title":"Analysis of NIA and GSNOR family genes and nitric oxide homeostasis in response to wheat-leaf rust interaction.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35039546","citation_count":8,"is_preprint":false},{"pmid":"33780653","id":"PMC_33780653","title":"Bronchopulmonary Dysplasia and Pulmonary Hypertension. The Role of Smooth Muscle adh5.","date":"2021","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/33780653","citation_count":7,"is_preprint":false},{"pmid":"24654711","id":"PMC_24654711","title":"Activation of GSNOR transcription by NF-κB negatively regulates NGF-induced PC12 differentiation.","date":"2014","source":"Free radical research","url":"https://pubmed.ncbi.nlm.nih.gov/24654711","citation_count":7,"is_preprint":false},{"pmid":"38570588","id":"PMC_38570588","title":"GSNOR negatively regulates the NLRP3 inflammasome via S-nitrosation of MAPK14.","date":"2024","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38570588","citation_count":7,"is_preprint":false},{"pmid":"32418890","id":"PMC_32418890","title":"Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke.","date":"2020","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/32418890","citation_count":7,"is_preprint":false},{"pmid":"29606625","id":"PMC_29606625","title":"S-Nitrosoglutathione Reductase (GSNOR) Deficiency Results in Secondary Hypogonadism.","date":"2018","source":"The journal of sexual medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29606625","citation_count":6,"is_preprint":false},{"pmid":"32665066","id":"PMC_32665066","title":"Familial Dysalbuminemic Hyperthyroxinemia (FDH), Albumin Gene Variant (R218S), and Risk of Miscarriages in Offspring.","date":"2020","source":"The American journal of the medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32665066","citation_count":5,"is_preprint":false},{"pmid":"34219079","id":"PMC_34219079","title":"[Aldehyde degradation deficiency (ADD) syndrome: discovery of a novel fanconi anemia-like inherited BMF syndrome due to combined ADH5/ALDH2 deficiency].","date":"2021","source":"[Rinsho ketsueki] The Japanese journal of clinical hematology","url":"https://pubmed.ncbi.nlm.nih.gov/34219079","citation_count":5,"is_preprint":false},{"pmid":"34458631","id":"PMC_34458631","title":"Trigenic ADH5/ALDH2/ADGRV1 mutations in myelodysplasia with Usher syndrome.","date":"2021","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/34458631","citation_count":5,"is_preprint":false},{"pmid":"37615925","id":"PMC_37615925","title":"Effects of the major formaldehyde catalyzer ADH5 on phenotypes of fanconi anemia zebrafish model.","date":"2023","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/37615925","citation_count":4,"is_preprint":false},{"pmid":"38330777","id":"PMC_38330777","title":"Differential S-nitrosylation and characterization of purified S-nitrosoglutathione reductase (GSNOR) from Brassica juncea shows multiple forms of the enzyme.","date":"2024","source":"Plant physiology and biochemistry : PPB","url":"https://pubmed.ncbi.nlm.nih.gov/38330777","citation_count":4,"is_preprint":false},{"pmid":"34790975","id":"PMC_34790975","title":"S-nitrosoglutathione reductase (GSNOR) deficiency accelerates cardiomyocyte differentiation of induced pluripotent stem cells.","date":"2021","source":"The journal of cardiovascular aging","url":"https://pubmed.ncbi.nlm.nih.gov/34790975","citation_count":4,"is_preprint":false},{"pmid":"40539224","id":"PMC_40539224","title":"Phytophthora Disrupts Plant Immunity by Manipulating Nitric Oxide Homeostasis Through GSNOR Inhibition.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40539224","citation_count":4,"is_preprint":false},{"pmid":"33545099","id":"PMC_33545099","title":"GSNOR and ALDH2 alleviate traumatic spinal cord injury.","date":"2021","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/33545099","citation_count":4,"is_preprint":false},{"pmid":"31766125","id":"PMC_31766125","title":"Evidence for an Allosteric S-Nitrosoglutathione Binding Site in S-Nitrosoglutathione Reductase (GSNOR).","date":"2019","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/31766125","citation_count":4,"is_preprint":false},{"pmid":"31582975","id":"PMC_31582975","title":"A Chinese Family with Familial Dysalbuminemic Hyperthyroxinemia (FDH) due to R242H Mutation on Human Albumin Gene: Reevaluating the Role of FDH in Patients with Asymptomatic Hyperthyroxinemia.","date":"2019","source":"International journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31582975","citation_count":4,"is_preprint":false},{"pmid":"37294852","id":"PMC_37294852","title":"Stable and Reusable Fe3 O4 /ZIF-8 Composite for Encapsulation of FDH Enzyme under Mild Conditions Applicable to CO2 Reduction.","date":"2023","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37294852","citation_count":4,"is_preprint":false},{"pmid":"6372555","id":"PMC_6372555","title":"Aldehyde oxidase and alcohol dehydrogenase genetics in the mouse. New alleles for the Aox-2 and Adh-3 loci.","date":"1983","source":"Animal blood groups and biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/6372555","citation_count":4,"is_preprint":false},{"pmid":"34790976","id":"PMC_34790976","title":"GSNOR regulates cardiomyocyte differentiation and maturation through protein S-nitrosylation.","date":"2021","source":"The journal of cardiovascular aging","url":"https://pubmed.ncbi.nlm.nih.gov/34790976","citation_count":3,"is_preprint":false},{"pmid":"39127141","id":"PMC_39127141","title":"Melatonin derivative 6a protects Caenorhabditis elegans from formaldehyde neurotoxicity via ADH5.","date":"2024","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39127141","citation_count":3,"is_preprint":false},{"pmid":"39532197","id":"PMC_39532197","title":"The role of S-nitrosoglutathione reductase (GSNOR) in T cell-mediated immunopathology of experimental autoimmune encephalomyelitis (EAE).","date":"2024","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39532197","citation_count":3,"is_preprint":false},{"pmid":"9241435","id":"PMC_9241435","title":"Genetic mapping of a possible new alcohol dehydrogenase sequence to mouse chromosome 3 at the Adh-1/Adh-3 complex.","date":"1997","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9241435","citation_count":3,"is_preprint":false},{"pmid":"40640557","id":"PMC_40640557","title":"ADH5/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implications.","date":"2025","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/40640557","citation_count":2,"is_preprint":false},{"pmid":"40407326","id":"PMC_40407326","title":"GSNOR plays roles in growth, pathogenicity, and stress resistance by modulating mitochondrial protein COX6B S-nitrosylation in Colletotrichum gloeosporioides.","date":"2025","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/40407326","citation_count":2,"is_preprint":false},{"pmid":"40494828","id":"PMC_40494828","title":"Design, Synthesis, and Anti-ischemic Stroke Activity Evaluation of Novel GSNOR Inhibitors.","date":"2025","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40494828","citation_count":1,"is_preprint":false},{"pmid":"41373639","id":"PMC_41373639","title":"The Central Role of GSNOR: Decoding Nitric Oxide Signaling for Crop Stress Tolerance.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41373639","citation_count":1,"is_preprint":false},{"pmid":"41612626","id":"PMC_41612626","title":"S-nitrosylation of GSNOR and LCD facilitates cadmium-induced programmed cell death in tomato seedlings.","date":"2026","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/41612626","citation_count":1,"is_preprint":false},{"pmid":"37761331","id":"PMC_37761331","title":"Immunohistochemical Staining Characteristics of Low-Grade Invasive Ductal Carcinoma Using the ADH5 Cocktail (CK5/14, P63, and CK7/18): A Potential Interpretative Pitfall.","date":"2023","source":"Diagnostics (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/37761331","citation_count":1,"is_preprint":false},{"pmid":"15321667","id":"PMC_15321667","title":"The fdh operon of Sulfurospirillum multivorans.","date":"2004","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/15321667","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49221,"output_tokens":6437,"usd":0.122109},"stage2":{"model":"claude-opus-4-6","input_tokens":10123,"output_tokens":4977,"usd":0.26256},"total_usd":0.384669,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1984,\n      \"finding\": \"Human formaldehyde dehydrogenase (FDH/ADH5) is a dimeric enzyme encoded on chromosome 4, with a functional molecule composed of two identical subunits.\",\n      \"method\": \"Biochemical isozyme analysis, somatic cell hybrid mapping\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical characterization and chromosomal mapping, single study\",\n      \"pmids\": [\"6467984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"ADH5 (FDH) gene is composed of nine exons and eight introns; its 5' region is a CpG island lacking TATA and CAAT boxes, consistent with ubiquitous expression; two major transcription start points were identified; and a 1.5-kb upstream fragment drives transcription in heterologous cells.\",\n      \"method\": \"Genomic cloning, primer extension, reporter gene (CAT) assay\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct molecular characterization with mutagenesis-equivalent reporter assays\",\n      \"pmids\": [\"1446828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Sp1 drives ADH5/FDH transcription through two core cis-elements (−22 bp to +22 bp); Sp3 and Sp4 repress transcription by competing with Sp1 for these same binding sites via their zinc-finger domains.\",\n      \"method\": \"Mutagenesis of cis-elements, reporter assay in Drosophila SL2 cells (lacking Sp1), EMSA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in Sp1-null cells with mutagenesis and EMSA, replicated across multiple cell types\",\n      \"pmids\": [\"9867805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The human ADH5 gene produces at least two transcript variants via alternative polyadenylation/splicing at a composite internal/terminal exon, generating C-terminal multiplicity; the full-length variant is the major transcript in adult liver.\",\n      \"method\": \"PCR amplification of 3'-cDNA ends, Northern blot, genomic sequencing\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple molecular methods in single study\",\n      \"pmids\": [\"11095947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The POZ domain transcription factor FBI-1 binds the ADH5/FDH promoter (−38 to −22 bp) in vitro and in vivo, represses ADH5/FDH transcription by directly interacting with the zinc-finger domain of Sp1, and interferes with Sp1 binding to GC boxes.\",\n      \"method\": \"EMSA, ChIP, GST pull-down, DNase I footprinting, reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including pull-down and footprinting in a single study\",\n      \"pmids\": [\"12004059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GSNOR (ADH5) deficiency leads to S-nitrosylation and proteasomal degradation of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT), impairing repair of O6-alkylguanines and promoting hepatocarcinogenesis; this is abrogated by concomitant iNOS deficiency.\",\n      \"method\": \"GSNOR knockout mice, carcinogen challenge, biochemical AGT quantification, epistasis with iNOS KO\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined molecular phenotype and genetic epistasis, replicated in multiple models\",\n      \"pmids\": [\"20371487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Overexpression of fdh (Drosophila GSNOR homolog) in the fan-shaped body (but not mushroom body) impairs visual pattern memory; the defect is rescued by co-expression of cGMP-dependent protein kinase (PKG), linking GSNOR-dependent NO/S-nitrosation metabolism to learning and memory via the NO-cGMP-PKG pathway.\",\n      \"method\": \"Gal4/UAS system for tissue-specific overexpression in Drosophila, behavioral assays, enzymatic activity measurement\",\n      \"journal\": \"Nitric oxide : biology and chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic manipulation with defined cellular/behavioral phenotype and epistasis rescue\",\n      \"pmids\": [\"20932929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Targeted hepatocyte-specific deletion of GSNOR (ADH5), but not hematopoietic-lineage deletion, leads to S-nitrosylation and depletion of AGT, increased DNA double-strand breaks, and elevated sensitivity to nitrosamine-induced genotoxicity; this is abolished by iNOS co-deficiency.\",\n      \"method\": \"Conditional (cell-type-specific) knockout mice, liver AGT quantification, γH2AX staining, epistasis with iNOS\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with defined molecular phenotype and genetic epistasis\",\n      \"pmids\": [\"21385828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GSNOR (ADH5) deficiency promotes hepatocellular carcinoma at the tumor initiation stage; pharmacological iNOS inhibition (1400W) after carcinogen exposure rescues AGT depletion and O6-ethyldeoxyguanosine repair and reduces HCC multiplicity in GSNOR-deficient mice to wild-type levels.\",\n      \"method\": \"GSNOR KO mice, pharmacological iNOS inhibition, DNA adduct measurement, tumor endpoint analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and genetic epistasis with molecular readouts, replicated\",\n      \"pmids\": [\"23440427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GSNOR deficiency in mesenchymal stem cells impairs vasculogenesis by downregulating PDGFRα, a receptor essential for VEGF-A action; restoration through NOS inhibition or GHRH agonists normalizes tube formation via PDGFRα.\",\n      \"method\": \"GSNOR KO MSCs, Matrigel tube-forming assay, pharmacological NOS inhibition, in vivo implantation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches including in vitro and in vivo models with pharmacological rescue\",\n      \"pmids\": [\"23288904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Human GSNOR (ADH5) is inhibited by S-nitrosation of conserved non-zinc-coordinating cysteine residues; nitrosation causes decreased tryptophan fluorescence, increased thermal aggregation, and increased polydispersity, with allosteric conformational changes near the substrate- and coenzyme-binding pockets detected by HDX-MS; DTT restores activity.\",\n      \"method\": \"In vitro enzyme assay with nitroso donors, mass spectrometry (S-nitrosation detection), HDX-MS, site-directed mutagenesis of cysteines, fluorescence, thermal stability assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis, mass spectrometry confirmation, and structural dynamics by HDX-MS\",\n      \"pmids\": [\"27064847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GSNOR (ADH5) metabolizes GSNO (S-nitrosoglutathione), S-hydroxymethylglutathione (the spontaneous formaldehyde-glutathione adduct), and some alcohols; it modulates NO bioavailability and indirectly regulates protein S-nitrosylation through GSNO-mediated transnitrosation.\",\n      \"method\": \"Enzymatic substrate characterization (review of biochemical data)\",\n      \"journal\": \"Critical reviews in biochemistry and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — established substrate specificity reviewed from multiple biochemical studies\",\n      \"pmids\": [\"28393572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GSNOR (ADH5) expression increases in the hippocampus during aging; GSNOR transgenic mice show cognitive impairment, LTP defects, and lower dendritic spine density; these are associated with decreased S-nitrosation of CaMKIIα at C280/C289, reducing CaMKIIα synaptosomal accumulation and downstream p(S831)-GluR1 signaling; GSNOR KO mice rescue age-related cognitive impairment.\",\n      \"method\": \"Transgenic overexpression and KO mice, behavioral tests (Morris water maze, fear conditioning, Y-maze), LTP recording, synaptosomal fractionation, site-directed mutagenesis of CaMKIIα S-nitrosation sites\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including mutagenesis of modification sites, behavioral, electrophysiological, and biochemical readouts\",\n      \"pmids\": [\"28883020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GSNOR deficiency increases S-nitrosylation of Akt at Cys224 in T cells, reducing Akt phosphorylation at Ser473 and impairing Akt signaling; HHcy induces GSNOR, reducing S-nitrosylation and activating T cells, promoting atherosclerosis; adoptive transfer of GSNOR-/- T cells reduces atherosclerosis.\",\n      \"method\": \"Site-directed mutagenesis of Akt C224, GSNOR KO and ApoE KO mice, adoptive transfer, S-nitrosylation measurement\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis of modification site combined with KO genetics and adoptive transfer\",\n      \"pmids\": [\"29860106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GSNOR exhibits allosteric activation by its substrate GSNO; kinetic analysis revealed non-hyperbolic behavior with Hill coefficient ~1.75; an allosteric GSNO-binding site comprises residues Asn185, Lys188, Gly321, and Lys323 near the structural Zn2+-binding domain; site-directed mutagenesis of Lys188Ala and Lys323Ala abolishes allosteric behavior.\",\n      \"method\": \"Enzyme kinetics, molecular docking, HDX-MS, site-directed mutagenesis\",\n      \"journal\": \"Antioxidants (Basel, Switzerland)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinetics, mutagenesis confirming allosteric site residues, structural dynamics by HDX-MS\",\n      \"pmids\": [\"31766125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GSNOR co-localizes with nNOS at the sarcolemma of skeletal muscle cells and co-immunoprecipitates with nNOS in C2C12 cells and myofibers; GSNOR expression decreases in models of muscular dystrophy, aging, and ALS.\",\n      \"method\": \"Co-immunoprecipitation, co-localization (immunofluorescence), C2C12 differentiation model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP and co-localization, single lab\",\n      \"pmids\": [\"31043586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Digenic loss of ADH5 (formaldehyde dehydrogenase) and ALDH2 causes AMeD syndrome (aplastic anemia, mental retardation, dwarfism) due to formaldehyde accumulation and resultant DNA damage that overwhelms hematopoietic stem cell capacity; Adh5 E506K/E506K mice recapitulate features including dwarfism and hematopoietic failure.\",\n      \"method\": \"Patient exome sequencing, cellular formaldehyde tolerance assays, mouse knockin model (E506K), hematopoietic differentiation assays\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — disease modeling with patient-derived cells, mouse model recapitulation, and cellular mechanistic studies\",\n      \"pmids\": [\"33355142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GSNOR (ADH5) is induced at the translational level by hydrogen peroxide and mitochondrial ROS downstream of ATM kinase, which phosphorylates and activates CHK2 and p53; this ATM/GSNOR axis sustains mitophagy and protects against nitrosative and oxidative stress.\",\n      \"method\": \"Selective pharmacological inhibitors, siRNA knockdown, redox-insensitive ATM mutant expression, cell viability and mitophagy assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and genetic epistasis with multiple orthogonal methods\",\n      \"pmids\": [\"33245190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ADH5 loss in brown adipose tissue impairs cold-induced UCP1-dependent thermogenesis and worsens obesity-associated metabolic dysfunction; ADH5 expression is induced by the transcription factor HSF1, and HSF1 activation increases Adh5 expression and improves UCP1-mediated respiration.\",\n      \"method\": \"BAT-specific ADH5 KO, cold exposure, UCP1 S-nitrosylation measurement, HSF1 activator treatment, metabolic phenotyping\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific KO with defined metabolic phenotype and transcription factor identification\",\n      \"pmids\": [\"34788615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ADH5 is the primary defense against endogenous formaldehyde, with ALDH2 providing backup; ADH5/ALDH2-deficient iPSCs show defective cell expansion upon hematopoietic differentiation with increased DNA damage, which is reversed by an ALDH2 agonist (compound C1).\",\n      \"method\": \"Patient-derived iPSCs, hematopoietic differentiation assays, DNA damage quantification, SCE analysis, pharmacological rescue\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — disease-model iPSCs with defined molecular and cellular phenotypes and pharmacological rescue\",\n      \"pmids\": [\"33512438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GSNOR deficiency enhances S-nitrosylation of TBK1 at Cys423, inhibiting TBK1 kinase activity and reducing interferon production, thereby impairing antiviral innate immune responses to HSV-1 and VSV.\",\n      \"method\": \"GSNOR KO MEFs and macrophages, viral replication assays, S-nitrosylation site identification, Gsnor-/- mouse infection model\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined S-nitrosylation site and functional kinase activity assay\",\n      \"pmids\": [\"34678655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ADH5-maintained SNO homeostasis facilitates STING activation; GSNO induces S-nitrosylation of STING at Cys257, inhibiting its binding to cGAMP; ADH5 metabolizes GSNO to prevent this inhibitory S-nitrosylation, thereby licensing STING-dependent innate immunity against HSV-1 and Listeria.\",\n      \"method\": \"Adh5 KO mice, S-nitrosylation site mapping (Cys257 of STING), cGAMP binding assay, viral and bacterial infection models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO genetics, defined S-nitrosylation site, biochemical binding assay, multiple pathogen models\",\n      \"pmids\": [\"38409248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GSNOR deficiency leads to CDK5 S-nitrosylation at Cys83, inhibiting CDK5 kinase activity and CDK5-mediated autophagy, and attenuating MPTP-induced dopaminergic neuron loss in a Parkinson's disease mouse model.\",\n      \"method\": \"GSNOR KO mice, MPTP model, GSNOR inhibitor N6022, S-nitrosylation site identification, CDK5 kinase activity assay\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO and pharmacological inhibition with defined S-nitrosylation site and kinase activity readout\",\n      \"pmids\": [\"35918012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GSNOR is localized in mitochondria (in addition to cytoplasm); mitochondrial GSNOR denitrosylates ANT1 at Cys160, preventing mitochondrial dysfunction; cardiac-specific GSNOR KO worsens pressure-overload heart failure; restoring mitochondrial GSNOR or expressing non-nitrosylatable ANT1 C160A improves mitochondrial function and cardiac performance.\",\n      \"method\": \"Cellular fractionation, immunofluorescence, colloidal gold staining, cardiac-specific KO mice, AAV9-mediated mitochondria-targeted GSNOR overexpression, biotin-switch/LC-MS/MS for S-nitrosylation site identification, ANT1 C160A mutagenesis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — novel subcellular localization confirmed by multiple methods, mutagenesis of modification site, KO phenotype, rescue experiment\",\n      \"pmids\": [\"37377022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GSNOR deficiency induces S-nitrosylation of focal adhesion kinase 1 (FAK1) at Cys658, enhancing FAK1 autophosphorylation and providing cancer cells with anoikis resistance; GSNOR-deficient tumors are sensitive to FAK1 inhibitors.\",\n      \"method\": \"Multiple tumor models, S-nitrosylation site mapping (C658), FAK1 kinase activity assay, pharmacological FAK1 inhibitors, GSNOR KO\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined S-nitrosylation site with functional kinase assay, multiple tumor models\",\n      \"pmids\": [\"36656716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GSNOR deficiency leads to S-nitrosylation of MAPK14 (p38) at Cys211, augmenting MAPK14 kinase activity and promoting NLRP3 and IL-1β transcription; GSNOR-/-Nlrp3-/- double KO mice show reduced severity of LPS-induced septic shock and DSS-induced colitis.\",\n      \"method\": \"GSNOR KO macrophages, double KO mice, S-nitrosylation site identification, MAPK14 kinase activity assay, in vivo disease models\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined S-nitrosylation site with kinase activity, genetic epistasis in two disease models\",\n      \"pmids\": [\"38570588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NEDD4 E3 ubiquitin ligase ubiquitinates GSNOR, targeting it for proteasomal degradation during cardiac hypertrophy; NEDD4 enzyme-dead mutant and non-ubiquitylatable GSNOR mutant decrease GSNOR ubiquitination and inhibit hypertrophic growth; cardiac-specific NEDD4 deficiency inhibits hypertrophy.\",\n      \"method\": \"Mass spectrometry for ubiquitin ligase identification, NEDD4 cardiomyocyte-specific KO mice, enzyme-dead NEDD4 mutant, GSNOR non-ubiquitylatable mutant, NEDD4 inhibitor (IBM)\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — identified E3 ligase by MS, mutagenesis of ubiquitination sites, conditional KO phenotype\",\n      \"pmids\": [\"39846173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NF-κB binds an essential responsive sequence (−88 to −73 bp) in the GSNOR promoter in response to NGF/TrkA/MEK1/2 signaling to activate GSNOR transcription; GSNOR overexpression suppresses NGF-induced PC12 neurite outgrowth, while GSNOR knockdown promotes differentiation.\",\n      \"method\": \"Luciferase reporter assay, EMSA, ChIP, pharmacological inhibition of TrkA and MEK1/2, GSNOR overexpression and knockdown\",\n      \"journal\": \"Free radical research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — EMSA, ChIP, and reporter assays combined with gain/loss-of-function in PC12 cells\",\n      \"pmids\": [\"24654711\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ADH5/GSNOR is a cytoplasmic (and mitochondrial) denitrosylase that catalyzes NADH-dependent reduction of GSNO (and S-hydroxymethylglutathione/formaldehyde-GSH adduct), thereby controlling intracellular protein S-nitrosylation; it directly denitrosylates specific substrates (ANT1, AGT, CaMKIIα, TBK1, STING, FAK1, Akt, CDK5, MAPK14) at defined cysteines to regulate their activity, and its own activity and abundance are regulated by S-nitrosation of conserved cysteines (autoinhibitory feedback), allosteric GSNO binding, ATM-CHK2-p53-dependent translational induction under oxidative stress, and NEDD4-mediated ubiquitin-proteasomal degradation; transcription is driven by Sp1 (repressed by Sp3/Sp4 and FBI-1) and induced by NF-κB and HSF1 in specific cellular contexts.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ADH5 (GSNOR/FDH) is a ubiquitously expressed, NAD⁺/NADH-dependent oxidoreductase that serves dual roles as the principal enzyme metabolizing S-nitrosoglutathione (GSNO) to control protein S-nitrosylation and as the primary cytoplasmic (and mitochondrial) formaldehyde dehydrogenase that detoxifies endogenous formaldehyde via its glutathione adduct S-hydroxymethylglutathione [PMID:28393572, PMID:37377022]. Through GSNO catabolism, ADH5 denitrosylates a growing roster of substrates at defined cysteines—including AGT, CaMKIIα, TBK1, STING, FAK1, Akt, CDK5, MAPK14, and ANT1—thereby calibrating DNA repair, innate immunity, kinase signaling, synaptic plasticity, and mitochondrial integrity [PMID:20371487, PMID:28883020, PMID:34678655, PMID:38409248, PMID:36656716, PMID:35918012, PMID:38570588, PMID:37377022, PMID:29860106]. ADH5 activity is itself regulated by product-feedback S-nitrosation of non-zinc cysteines, allosteric activation by GSNO, ATM–CHK2–p53-dependent translational induction under oxidative stress, NEDD4-mediated ubiquitin-proteasomal degradation, and transcriptional control by Sp1 (opposed by Sp3/Sp4 and FBI-1), NF-κB, and HSF1 [PMID:27064847, PMID:31766125, PMID:33245190, PMID:39846173, PMID:9867805, PMID:12004059, PMID:24654711, PMID:34788615]. Digenic loss of ADH5 and ALDH2 causes AMeD syndrome (aplastic anemia, mental retardation, dwarfism) through toxic formaldehyde accumulation and hematopoietic stem cell failure [PMID:33355142, PMID:33512438].\",\n  \"teleology\": [\n    {\n      \"year\": 1984,\n      \"claim\": \"Establishing the gene identity: ADH5 was shown to encode a dimeric formaldehyde dehydrogenase mapped to chromosome 4, providing the first molecular characterization of the enzyme later recognized as GSNOR.\",\n      \"evidence\": \"Biochemical isozyme analysis and somatic cell hybrid mapping\",\n      \"pmids\": [\"6467984\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study; protein structure and catalytic mechanism unresolved\", \"Substrate specificity beyond formaldehyde-GSH adduct not yet explored\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Defining the gene structure and housekeeping expression: the ADH5 gene was shown to comprise nine exons with a CpG-island promoter lacking TATA/CAAT boxes, explaining its ubiquitous expression.\",\n      \"evidence\": \"Genomic cloning, primer extension, CAT reporter assay\",\n      \"pmids\": [\"1446828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcription factor binding not yet defined\", \"No functional link to NO metabolism established\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying the core transcriptional machinery: Sp1 was established as the principal activator of ADH5 transcription through two cis-elements near the start site, with Sp3/Sp4 acting as competitive repressors—revealing how ubiquitous yet tunable expression is achieved.\",\n      \"evidence\": \"Mutagenesis of cis-elements, reporter assays in Sp1-null Drosophila SL2 cells, EMSA\",\n      \"pmids\": [\"9867805\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal-responsive transcriptional regulation not yet addressed\", \"No post-translational regulatory mechanism known\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Revealing promoter fine-tuning: the POZ-domain factor FBI-1 was shown to repress ADH5 transcription by binding upstream of the Sp1 sites and disrupting Sp1–DNA interaction, adding a repressive layer to ADH5 regulation.\",\n      \"evidence\": \"EMSA, ChIP, GST pull-down, DNase I footprinting, reporter assay\",\n      \"pmids\": [\"12004059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context for FBI-1-mediated repression unclear\", \"No connection to NO signaling yet\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Linking GSNOR to cancer via denitrosylation of a DNA repair protein: GSNOR deficiency was shown to cause iNOS-dependent S-nitrosylation and proteasomal degradation of AGT, impairing O⁶-alkylguanine repair and promoting hepatocellular carcinoma—the first demonstration that GSNOR protects genome integrity through substrate-specific denitrosylation.\",\n      \"evidence\": \"GSNOR KO mice, carcinogen challenge, biochemical AGT quantification, epistasis with iNOS KO\",\n      \"pmids\": [\"20371487\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct S-nitrosylation site on AGT not mapped\", \"Mechanism of nitrosylation-induced AGT degradation not fully defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolving the cell-autonomous origin of GSNOR's tumor-suppressive role: hepatocyte-specific, but not hematopoietic-lineage, GSNOR deletion recapitulated AGT depletion and genotoxic sensitivity, demonstrating that the protective function is intrinsic to the parenchymal cell.\",\n      \"evidence\": \"Conditional cell-type-specific KO mice, γH2AX staining, iNOS epistasis\",\n      \"pmids\": [\"21385828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full spectrum of hepatocyte S-nitrosoproteome changes not catalogued\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovering signal-responsive transcriptional induction: NF-κB was shown to bind the GSNOR promoter and activate transcription in response to NGF/TrkA/MEK signaling, while GSNOR overexpression suppressed neurite outgrowth—linking GSNOR transcription to differentiation signaling.\",\n      \"evidence\": \"Luciferase reporter, EMSA, ChIP, pharmacological inhibition, gain/loss-of-function in PC12 cells\",\n      \"pmids\": [\"24654711\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NF-κB regulation is generalizable beyond NGF/PC12 context unclear\", \"Direct NOS isoform involvement in neurite outgrowth not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealing autoinhibitory feedback: S-nitrosation of GSNOR's own non-zinc cysteines was shown to inhibit enzyme activity with allosteric conformational changes near the active site—establishing a product-feedback mechanism that limits GSNOR activity under high nitrosative stress.\",\n      \"evidence\": \"In vitro enzyme assay, mass spectrometry, HDX-MS, site-directed cysteine mutagenesis\",\n      \"pmids\": [\"27064847\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of GSNOR self-nitrosation in vivo not demonstrated\", \"Identity of specific inhibitory cysteines in vivo not fully resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extending GSNOR function to synaptic plasticity and aging: age-dependent GSNOR upregulation was shown to reduce CaMKIIα S-nitrosylation at C280/C289, impairing synaptosomal CaMKIIα accumulation and LTP, while GSNOR KO rescued age-related cognitive decline.\",\n      \"evidence\": \"GSNOR transgenic and KO mice, Morris water maze, LTP recording, CaMKIIα site-directed mutagenesis\",\n      \"pmids\": [\"28883020\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether direct GSNOR–CaMKIIα interaction occurs is unknown\", \"Upstream signal driving age-dependent GSNOR induction not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Uncovering allosteric activation by substrate: GSNOR kinetics showed non-hyperbolic (cooperative) behavior with GSNO; mutagenesis of Lys188 and Lys323 at a distinct allosteric site abolished cooperativity—revealing a feed-forward mechanism that accelerates GSNO clearance at rising concentrations.\",\n      \"evidence\": \"Enzyme kinetics, HDX-MS, molecular docking, site-directed mutagenesis (K188A, K323A)\",\n      \"pmids\": [\"31766125\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of GSNO-bound allosteric site not obtained\", \"Physiological GSNO concentration dynamics in vivo not measured\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Connecting ADH5 to a Mendelian disease: digenic ADH5/ALDH2 loss was shown to cause AMeD syndrome through toxic formaldehyde accumulation that damages DNA and exhausts hematopoietic stem cells, with an Adh5-E506K knockin mouse recapitulating the phenotype.\",\n      \"evidence\": \"Patient exome sequencing, formaldehyde tolerance assays, mouse knockin model, hematopoietic differentiation\",\n      \"pmids\": [\"33355142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of GSNO denitrosylase vs. formaldehyde dehydrogenase activity to disease unclear\", \"Tissue-specific vulnerability beyond hematopoietic system not fully explored\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identifying oxidative-stress-responsive translational regulation: hydrogen peroxide and mitochondrial ROS were shown to induce GSNOR protein via ATM→CHK2→p53 signaling at the translational level, coupling GSNOR abundance to the cellular redox state and sustaining mitophagy.\",\n      \"evidence\": \"Pharmacological inhibitors, siRNA, redox-insensitive ATM mutant, mitophagy assays\",\n      \"pmids\": [\"33245190\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Translational mechanism (IRES, uORF, etc.) not defined\", \"Whether this regulation operates in vivo not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linking ADH5 to thermogenesis: BAT-specific ADH5 KO impaired cold-induced UCP1-dependent thermogenesis, and HSF1 was identified as an ADH5 transcriptional inducer in this tissue, connecting NO homeostasis to metabolic adaptation.\",\n      \"evidence\": \"BAT-specific KO mice, cold exposure, UCP1 S-nitrosylation measurement, HSF1 activator treatment\",\n      \"pmids\": [\"34788615\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct HSF1 binding site on ADH5 promoter not mapped\", \"UCP1 S-nitrosylation site not identified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defining GSNOR's role in antiviral innate immunity: GSNOR deficiency increased S-nitrosylation of TBK1 at Cys423 (inhibiting its kinase activity and interferon production) and of STING at Cys257 (blocking cGAMP binding), establishing GSNOR as a prerequisite for effective cGAS-STING and TBK1 signaling.\",\n      \"evidence\": \"GSNOR KO MEFs/macrophages, viral replication assays, S-nitrosylation site mapping, cGAMP binding assay, in vivo infection models\",\n      \"pmids\": [\"34678655\", \"38409248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GSNOR directly denitrosylates TBK1/STING or acts only via GSNO clearance is unclear\", \"Relative contribution of TBK1 vs. STING nitrosylation to immune phenotype not dissected\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extending denitrosylation targets to neurodegeneration: GSNOR deficiency was shown to S-nitrosylate CDK5 at Cys83, inhibiting CDK5 kinase activity and autophagy, and attenuating MPTP-induced dopaminergic neuron loss—positioning GSNOR as a modulator of Parkinson's disease pathology.\",\n      \"evidence\": \"GSNOR KO mice, MPTP model, GSNOR inhibitor N6022, S-nitrosylation site identification, CDK5 kinase assay\",\n      \"pmids\": [\"35918012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CDK5 inhibition is neuroprotective or neurotoxic in long-term models not resolved\", \"Effect of GSNOR inhibition on broader SNO-proteome in brain not profiled\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovering mitochondrial localization and a cardiac-protective denitrosylation target: GSNOR was found in mitochondria where it denitrosylates ANT1 at Cys160; cardiac-specific GSNOR KO worsened heart failure, while mitochondria-targeted GSNOR or ANT1-C160A rescued mitochondrial and cardiac function.\",\n      \"evidence\": \"Cellular fractionation, immunofluorescence, colloidal gold staining, cardiac-specific KO, AAV9-mitochondrial GSNOR, ANT1 C160A mutagenesis, LC-MS/MS\",\n      \"pmids\": [\"37377022\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mitochondrial import mechanism for GSNOR not identified\", \"Breadth of mitochondrial SNO targets beyond ANT1 unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Linking GSNOR loss to anoikis resistance in cancer: GSNOR deficiency was shown to S-nitrosylate FAK1 at Cys658, enhancing FAK1 autophosphorylation and conferring anoikis resistance; GSNOR-deficient tumors were sensitive to FAK1 inhibitors.\",\n      \"evidence\": \"Multiple tumor models, S-nitrosylation site mapping, FAK1 kinase assay, pharmacological FAK1 inhibition\",\n      \"pmids\": [\"36656716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FAK1 S-nitrosylation drives metastasis in vivo not tested\", \"Therapeutic window for FAK inhibition in GSNOR-low tumors not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealing a pro-inflammatory consequence of GSNOR loss: GSNOR deficiency S-nitrosylated MAPK14 at Cys211, augmenting its kinase activity and driving NLRP3 inflammasome transcription; double KO with Nlrp3 rescued sepsis and colitis severity.\",\n      \"evidence\": \"GSNOR KO macrophages, double KO mice, S-nitrosylation site ID, MAPK14 kinase assay, LPS sepsis and DSS colitis models\",\n      \"pmids\": [\"38570588\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MAPK14 Cys211 nitrosylation occurs in human inflammatory disease not shown\", \"Role of other MAPKs as GSNOR targets not assessed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identifying the E3 ligase controlling GSNOR turnover: NEDD4 was shown to ubiquitinate GSNOR and target it for proteasomal degradation during cardiac hypertrophy; enzyme-dead NEDD4 or non-ubiquitylatable GSNOR mutant blocked this degradation and inhibited hypertrophy.\",\n      \"evidence\": \"Mass spectrometry for E3 ligase identification, cardiomyocyte-specific NEDD4 KO, enzyme-dead mutant, non-ubiquitylatable GSNOR mutant\",\n      \"pmids\": [\"39846173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific ubiquitination sites on GSNOR not mapped\", \"Whether NEDD4-GSNOR axis operates outside cardiac tissue unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for substrate selectivity among diverse S-nitrosylated targets; the mechanism of GSNOR import into mitochondria; how the balance between GSNOR's denitrosylase and formaldehyde dehydrogenase activities is regulated in different tissues; and whether pharmacological GSNOR modulation can be therapeutically exploited in cancer, neurodegeneration, and heart failure.\",\n      \"evidence\": \"Open questions derived from current literature\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of GSNOR bound to a protein S-nitrosylation substrate\", \"Mitochondrial targeting signal or import mechanism unknown\", \"No clinical trials of GSNOR-targeted therapy reported\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 10, 11, 14]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 12, 13, 20, 21, 22, 23, 24, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11, 23]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [5, 7, 8, 16, 19]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [20, 21, 25]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [13, 24, 27]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 8, 16]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [10, 17]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [11, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"AGT\",\n      \"CAMK2A\",\n      \"TBK1\",\n      \"STING1\",\n      \"FAK1\",\n      \"AKT1\",\n      \"CDK5\",\n      \"NEDD4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}